Finally, our study pinpointed LPC and LPA as key downstream metabolites and established the ACSL1‐LPC‐ATX‐LPA axis as an intricate metabolic pathway that aggravates thromboinflammation in AMI due to hyperlipidemia. Here, ACSL1 is linked to hyperlipidemia.